
Description
Developing a vaccine during the midst of a pandemic requires a careful balance between <br/>speed, safety, and efficacy. For the COVID-19 pandemic, the U.S. implemented Operation Warp Speed to accelerate the timeline for vaccine development. The FDA also imposed specific guidelines for granting Emergency Use Authorization (EUA).
Download count: 0
Details
Contributors
- Dykstra, Tatum Nicole (Author)
- Brian, Jennifer (Thesis director)
- Koskan, Alexis (Committee member)
- School of Life Sciences (Contributor)
- College of Health Solutions (Contributor)
- Barrett, The Honors College (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2021-05
Subjects
Resource Type
Collections this item is in